Not applicableNot Yet RecruitingNCT07645742What this trial is testingPilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsWho this might be right forCancer (Advanced Stage) West Virginia University 90
Not applicableStudy completedNCT00723710What this trial is testingEffect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)Who this might be right forMelanoma Merck Sharp & Dohme LLC 299
Post-approval studies (Phase 4)Ended earlyNCT01683188What this trial is testingHD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic MelanomaWho this might be right forMetastatic Melanoma Clinigen, Inc. 53
Testing effectiveness (Phase 2)Looking for participantsNCT07410494What this trial is testingBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forCancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more Essen Biotech 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT04722575What this trial is testingCombination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable MelanomaWho this might be right forMelanoma Fondazione Melanoma Onlus 95
Testing effectiveness (Phase 2)UnknownNCT00492505What this trial is testingSorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III MelanomaWho this might be right forMelanoma (Skin) San Diego Pacific Oncology & Hematology Associates 200
Testing effectiveness (Phase 2)Study completedNCT00616564What this trial is testingPhase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced MelanomaWho this might be right forMalignant Melanoma Mt. Sinai Medical Center, Miami 36
Testing effectiveness (Phase 2)Study completedNCT00463892What this trial is testingHigh-resolution Magnetic Resonance Imaging (MRI) Scans to Look for Spread of Melanoma to Nearby Lymph NodesWho this might be right forMelanoma Redwood Regional Medical Group 200
Not applicableLooking for participantsNCT03702309What this trial is testingLiquid Biopsy Evaluation and Repository Development at Princess MargaretWho this might be right forCancerBreast CancerLung Cancer+15 more University Health Network, Toronto 2,500
Post-approval studies (Phase 4)Looking for participantsNCT03340506What this trial is testingDabrafenib and/or Trametinib Rollover StudyWho this might be right forMelanomaNon Small Cell Lung CancerSolid Tumor+2 more Novartis Pharmaceuticals 100
Early research (Phase 1)Active Not RecruitingNCT04616248What this trial is testingIn Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid TumorsWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8+10 more University of Southern California 14
Testing effectiveness (Phase 2)Study completedNCT03554083What this trial is testingVemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Pathologic Stage III Cutaneous Melanoma AJCC v8Pathologic Stage IIIA Cutaneous Melanoma AJCC v8+3 more Mayo Clinic 64
Testing effectiveness (Phase 2)Study completedNCT00445965What this trial is testingIodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerWho this might be right forBrain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more Memorial Sloan Kettering Cancer Center 78
Early research (Phase 1)Study completedNCT00418496What this trial is testingInterleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic MelanomaWho this might be right forRenal CancerMelanoma Ohio State University Comprehensive Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT00199901What this trial is testingStudy of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected MelanomaWho this might be right forMelanoma Ludwig Institute for Cancer Research 111
Testing effectiveness (Phase 2)Looking for participantsNCT04114136What this trial is testingAnti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor MalignanciesWho this might be right forMelanomaNSCLCHepatocellular Carcinoma+5 more Dan Zandberg 72
Early research (Phase 1)Ended earlyNCT05909995What this trial is testingInterventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid TumorsWho this might be right forMelanomaHepatocellular Carcinoma (HCC)Renal Cell Carcinoma (RCC)+3 more Incyte Corporation 8
Very early researchLooking for participantsNCT07586904What this trial is testingEfficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.Who this might be right forMelanoma (Skin Cancer) Xijing Hospital 10
Not applicableStudy completedNCT00184275What this trial is testingCharacterization of Brain MetastasesWho this might be right forNeoplasm MetastasisLung NeoplasmsBreast Neoplasms+1 more Norwegian University of Science and Technology 26
Testing effectiveness (Phase 2)Study completedNCT01993719What this trial is testingImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic MelanomaWho this might be right forMetastatic Melanoma National Cancer Institute (NCI) 33